198 related articles for article (PubMed ID: 25152440)
1. Mitf regulates osteoclastogenesis by modulating NFATc1 activity.
Lu SY; Li M; Lin YL
Exp Cell Res; 2014 Oct; 328(1):32-43. PubMed ID: 25152440
[TBL] [Abstract][Full Text] [Related]
2. Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis.
Feng H; Cheng T; Steer JH; Joyce DA; Pavlos NJ; Leong C; Kular J; Liu J; Feng X; Zheng MH; Xu J
J Biol Chem; 2009 May; 284(21):14667-76. PubMed ID: 19321441
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
Asai K; Funaba M; Murakami M
Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
[TBL] [Abstract][Full Text] [Related]
4. AP-1 and Mitf interact with NFATc1 to stimulate cathepsin K promoter activity in osteoclast precursors.
Pang M; Rodríguez-Gonzalez M; Hernandez M; Recinos CC; Seldeen KL; Troen BR
J Cell Biochem; 2019 Aug; 120(8):12382-12392. PubMed ID: 30816596
[TBL] [Abstract][Full Text] [Related]
5. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
6. Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase.
Fretz JA; Shevde NK; Singh S; Darnay BG; Pike JW
Mol Endocrinol; 2008 Mar; 22(3):737-50. PubMed ID: 18063694
[TBL] [Abstract][Full Text] [Related]
7. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
8. TGF-β Negatively Regulates Mitf-E Expression and Canine Osteoclastogenesis.
Asai K; Hisasue M; Shimokawa F; Funaba M; Murakami M
Biochem Genet; 2018 Oct; 56(5):542-552. PubMed ID: 29680988
[TBL] [Abstract][Full Text] [Related]
9. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
Iwai K; Koike M; Ohshima S; Miyatake K; Uchiyama Y; Saeki Y; Ishii M
J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169
[TBL] [Abstract][Full Text] [Related]
10. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation.
Sharma SM; Bronisz A; Hu R; Patel K; Mansky KC; Sif S; Ostrowski MC
J Biol Chem; 2007 May; 282(21):15921-9. PubMed ID: 17403683
[TBL] [Abstract][Full Text] [Related]
11. Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis.
Kim Y; Sato K; Asagiri M; Morita I; Soma K; Takayanagi H
J Biol Chem; 2005 Sep; 280(38):32905-13. PubMed ID: 16046394
[TBL] [Abstract][Full Text] [Related]
12. MafB negatively regulates RANKL-mediated osteoclast differentiation.
Kim K; Kim JH; Lee J; Jin HM; Kook H; Kim KK; Lee SY; Kim N
Blood; 2007 Apr; 109(8):3253-9. PubMed ID: 17158225
[TBL] [Abstract][Full Text] [Related]
13. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
[TBL] [Abstract][Full Text] [Related]
14. SHP2 regulates osteoclastogenesis by promoting preosteoclast fusion.
Zhou Y; Mohan A; Moore DC; Lin L; Zhou FL; Cao J; Wu Q; Qin YX; Reginato AM; Ehrlich MG; Yang W
FASEB J; 2015 May; 29(5):1635-45. PubMed ID: 25593124
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo.
Franco GC; Kajiya M; Nakanishi T; Ohta K; Rosalen PL; Groppo FC; Ernst CW; Boyesen JL; Bartlett JD; Stashenko P; Taubman MA; Kawai T
Exp Cell Res; 2011 Jun; 317(10):1454-64. PubMed ID: 21420951
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis.
Jules J; Zhang P; Ashley JW; Wei S; Shi Z; Liu J; Michalek SM; Feng X
J Biol Chem; 2012 May; 287(19):15728-38. PubMed ID: 22416138
[TBL] [Abstract][Full Text] [Related]
17. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.
Tran PT; Dat NT; Dang NH; Van Cuong P; Lee S; Hwangbo C; Van Minh C; Lee JH
Phytomedicine; 2019 Mar; 55():1-8. PubMed ID: 30668419
[TBL] [Abstract][Full Text] [Related]
18. cIAP1/2 negatively regulate RANKL-induced osteoclastogenesis through the inhibition of NFATc1 expression.
Yamaguchi N; Yokota M; Taguchi Y; Gohda J; Inoue J
Genes Cells; 2012 Dec; 17(12):971-81. PubMed ID: 23126497
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis.
Kim K; Kim JH; Lee J; Jin HM; Lee SH; Fisher DE; Kook H; Kim KK; Choi Y; Kim N
J Biol Chem; 2005 Oct; 280(42):35209-16. PubMed ID: 16109714
[TBL] [Abstract][Full Text] [Related]
20. RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival.
Fujiwara T; Zhou J; Ye S; Zhao H
Cell Death Dis; 2016 Jul; 7(7):e2300. PubMed ID: 27441652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
